AbbVie (ABBV) Net Equity Issued and Repurchased (2013 - 2026)
AbbVie's Net Equity Issued and Repurchased was $48 million in Q4 2025, up 380.0% from $10 million a year earlier but down 23.8% from the prior quarter.
Powered by 
Analysis
AbbVie (ABBV) Net Equity Issued and Repurchased (2013 - 2026) Analysis & Trends
For FY2025, Net Equity Issued and Repurchased at AbbVie came in at $172 million, down 19.6% from FY2024.
- Net Equity Issued and Repurchased shows a five-year compound annual growth rate of -3.8% (FY2020 to FY2025).
- In earlier years, Net Equity Issued and Repurchased was $214 million in FY2024 (+18.9%), $180 million in FY2023 (-31.3%), $262 million in FY2022 (+7.4%) and $244 million in FY2021 (+16.7%).
- Quarterly Net Equity Issued and Repurchased has moved between $5 million (Q2 2025) and $128 million (Q1 2022) over five years.
- Compared with a year earlier, Net Equity Issued and Repurchased was higher in three of the last eight quarters, with growth averaging 37.8%.
- The best year-over-year quarter for Net Equity Issued and Repurchased over five years was Q1 2021 (growth of 491.7%); the worst was Q2 2024 (a decline of 79.2%).
- Per Business Quant data, ABBV's Net Equity Issued and Repurchased in the three quarters before Q4 2025 was $63 million (Q3 2025), $5 million (Q2 2025) and $56 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | -1.60 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 138.00 Mn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | -9.00 Mn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | -714.00 Mn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | -1.20 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 6.00 Mn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | -346.00 Mn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | - |
| 10 | Vertex Pharmaceuticals | 126.70 Bn | 98.70 Bn | 2.84 Bn | -421.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -9.00 Mn |
| Mar 31, 2026 | -1.49 Bn |
| Dec 31, 2025 | 45.00 Mn |
| Sep 30, 2025 | 59.00 Mn |
| Jun 30, 2025 | -7.00 Mn |
| Mar 31, 2025 | -905.00 Mn |
| Dec 31, 2024 | -348.00 Mn |
| Sep 30, 2024 | 50.00 Mn |
| Jun 30, 2024 | 1.00 Mn |
| Mar 31, 2024 | -1.20 Bn |
| Dec 31, 2023 | 28.00 Mn |
| Sep 30, 2023 | 32.00 Mn |
| Jun 30, 2023 | 38.00 Mn |
| Mar 31, 2023 | -1.89 Bn |
| Dec 31, 2022 | 49.00 Mn |
| Sep 30, 2022 | 7.00 Mn |
| Jun 30, 2022 | 61.00 Mn |
| Mar 31, 2022 | -1.34 Bn |
| Dec 31, 2021 | -56.00 Mn |
| Sep 30, 2021 | 19.00 Mn |
API Access
AbbVie Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();